NO20091055L - Gener for biosyntesen av epotiloner - Google Patents

Gener for biosyntesen av epotiloner

Info

Publication number
NO20091055L
NO20091055L NO20091055A NO20091055A NO20091055L NO 20091055 L NO20091055 L NO 20091055L NO 20091055 A NO20091055 A NO 20091055A NO 20091055 A NO20091055 A NO 20091055A NO 20091055 L NO20091055 L NO 20091055L
Authority
NO
Norway
Prior art keywords
epothilone
biosynthesis
genes
epothilones
cancer
Prior art date
Application number
NO20091055A
Other languages
English (en)
Inventor
Thomas Schupp
James Madison Ligon
Istvan Molnar
Ross Zirkle
Jorn Gorlach
Devon Cyr
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20091055L publication Critical patent/NO20091055L/no
Application filed by Novartis Ag filed Critical Novartis Ag

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Nukleinsyremolekyler ble isolert fra Sorangium cellulosum som koder for polypeptider som er nødvendige for biosyntesen av epotilon. Det er omtalt metoder for fremstillingen av epotilonet i rekombinante verter transformert med gener ifølge oppfinnelsen. Epotilonet kan på denne måten bli fremstilt i mengder som er store nok for å muliggjøre rensning av disse og anvendelse i farmasøytiske formuleringer slik som for behandlingen av cancer.
NO20091055A 1998-06-18 2009-03-09 Gener for biosyntesen av epotiloner NO20091055L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9950498A 1998-06-18 1998-06-18
US10163198P 1998-09-24 1998-09-24
US11890699P 1999-02-05 1999-02-05
PCT/EP1999/004171 WO1999066028A2 (en) 1998-06-18 1999-06-16 Genes for the biosynthesis of epothilones

Publications (1)

Publication Number Publication Date
NO20091055L true NO20091055L (no) 2001-02-16

Family

ID=27378840

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20006195A NO20006195L (no) 1998-06-18 2000-12-06 Gener for biosyntesen av epothiloner
NO20091055A NO20091055L (no) 1998-06-18 2009-03-09 Gener for biosyntesen av epotiloner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20006195A NO20006195L (no) 1998-06-18 2000-12-06 Gener for biosyntesen av epothiloner

Country Status (16)

Country Link
EP (1) EP1088078A2 (no)
JP (3) JP2002518004A (no)
KR (1) KR100511233B1 (no)
CN (1) CN100374565C (no)
AU (1) AU753567B2 (no)
BR (1) BR9911349A (no)
CA (1) CA2329774A1 (no)
HU (1) HUP0102186A3 (no)
ID (1) ID29128A (no)
IL (3) IL139735A0 (no)
NO (2) NO20006195L (no)
NZ (1) NZ508326A (no)
PL (1) PL200157B1 (no)
SK (1) SK19242000A3 (no)
TR (1) TR200003759T2 (no)
WO (1) WO1999066028A2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2273083C (en) 1996-12-03 2012-09-18 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6204388B1 (en) 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
FR2775187B1 (fr) 1998-02-25 2003-02-21 Novartis Ag Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
DE19846493A1 (de) * 1998-10-09 2000-04-13 Biotechnolog Forschung Gmbh DNA-Sequenzen für die enzymatische Synthese von Polyketid- oder Heteropolyketidverbindungen
WO2000031247A2 (en) 1998-11-20 2000-06-02 Kosan Biosciences, Inc. Recombinant methods and materials for producing epothilone and epothilone derivatives
US6410301B1 (en) 1998-11-20 2002-06-25 Kosan Biosciences, Inc. Myxococcus host cells for the production of epothilones
AU2001245263A1 (en) * 2000-01-21 2001-07-31 Kosan Biosciences, Inc. Method for cloning polyketide synthase genes
DK1652926T3 (da) * 2000-04-28 2010-02-15 Kosan Biosciences Inc Krystallinsk epothilon D
US6998256B2 (en) 2000-04-28 2006-02-14 Kosan Biosciences, Inc. Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate
US7257562B2 (en) 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
IL155306A0 (en) 2000-10-13 2003-11-23 Univ Mississippi Methods for producing epothilone derivatives and analogs and epothilone derivatives and analogs produced thereby
SI1483251T1 (sl) 2002-03-12 2010-03-31 Bristol Myers Squibb Co C cian epotilonski derivati
AU2006211216B2 (en) * 2005-01-31 2011-02-03 Merck Sharp & Dohme Llc Purification process for plasmid DNA
DK2668284T3 (en) 2011-01-28 2014-12-15 Amyris Inc Screening of colony micro encapsulated in gel
CA2834783A1 (en) 2011-05-13 2012-11-22 Amyris, Inc. Methods and compositions for detecting microbial production of water-immiscible compounds
AU2013299608B2 (en) 2012-08-07 2019-02-21 Amyris, Inc. Methods for stabilizing production of acetyl-coenzyme a derived compounds
JP6595449B2 (ja) 2013-03-15 2019-10-23 アミリス， インコーポレイテッド アセチル補酵素ａ由来化合物を生産するためのホスホケトラーゼおよびホスホトランスアセチラーゼの使用
BR112016002526B1 (pt) 2013-08-07 2021-11-23 Total Marketing Services Método para produção de um composto heterólogo não catabólico, e, composição de fermentação
US10808015B2 (en) 2015-06-25 2020-10-20 Amyris, Inc. Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds
CN106916834B (zh) * 2015-12-24 2022-08-05 武汉合生科技有限公司 化合物的生物合成基因簇及其应用
CN111138444B (zh) * 2020-01-08 2022-05-03 山东大学 一组埃博霉素b葡萄糖苷类化合物及其酶法制备与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2312695T3 (es) * 1996-11-18 2009-03-01 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Epotilones e y f.

Also Published As

Publication number Publication date
JP2006061166A (ja) 2006-03-09
CA2329774A1 (en) 1999-12-23
WO1999066028A2 (en) 1999-12-23
IL139735A (en) 2009-06-15
HUP0102186A2 (hu) 2001-10-28
KR100511233B1 (ko) 2005-08-31
EP1088078A2 (en) 2001-04-04
AU753567B2 (en) 2002-10-24
JP2002518004A (ja) 2002-06-25
HUP0102186A3 (en) 2005-10-28
SK19242000A3 (sk) 2001-07-10
PL200157B1 (pl) 2008-12-31
NO20006195D0 (no) 2000-12-06
AU4611699A (en) 2000-01-05
CN100374565C (zh) 2008-03-12
ID29128A (id) 2001-08-02
IL190391A0 (en) 2008-11-03
WO1999066028A3 (en) 2000-06-29
BR9911349A (pt) 2001-03-13
TR200003759T2 (tr) 2001-06-21
NO20006195L (no) 2001-02-16
KR20010052962A (ko) 2001-06-25
JP2008092958A (ja) 2008-04-24
CN1305530A (zh) 2001-07-25
IL139735A0 (en) 2002-02-10
NZ508326A (en) 2003-10-31
PL345579A1 (en) 2001-12-17

Similar Documents

Publication Publication Date Title
NO20091055L (no) Gener for biosyntesen av epotiloner
WO2002020500A3 (en) Materials and methods to potentiate cancer treatment
NO20030381L (no) Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser
ATE377597T1 (de) Anilinochinazoline als protein-tyrosin- kinasehemmer
WO2006124863A3 (en) Pyrrolopyridine derivatives as protein kinase inhibitors
ATE473980T1 (de) Triazolopyridazine als proteinkinase-inhibitoren
WO2005002552A3 (en) Benzimidazole derivatives and their use as protein kinases inhibitors
CY1108092T1 (el) Ενωσεις και μεθοδοι για την αναστολη της μιτωτικης προοδου με την αναστολη της κινασης aurora
UA91815C2 (ru) Выделенное антитело, которое специфически связывает gdf-8, и его применение
WO2004085418A3 (en) Xanthones, thioxanthones and acridinones as dna-pk inhibitors
WO2004078682A3 (en) Cyclic compounds and compositions as protein kinase inhibitors
WO2005014035A3 (en) Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
WO2008156614A3 (en) Imidazopyrazines as protein kinase inhibitors
WO2005042029A3 (en) Psma formulations and uses thereof
WO2007041358A3 (en) Substituted pyrazole compounds
WO2003080582A3 (de) Fredericamycin-derivate
WO2004043383A3 (en) A new target for angiogenesis and anti-angiogenesis therapy
WO2007067781A3 (en) 9-membered heterobicyclic compounds as inhibitors of protein kinases
NO20022202L (no) 5-aryl-1H-1,2,4-triazol forbindelser som inhibitorer av cyclooksygenase-2 og farmasöytiske preparater inneholdende disse
WO2004046332A3 (en) Amplified genes involved in cancer
BRPI0308606B8 (pt) compostos derivados de hemiasterlina e composição farmacêutica compreendendo os mesmos
IL179883A0 (en) 4,6-disubstituted pyrimidine derivatives and pharmaceutical compositions containing the same
NO20055209D0 (no) Peptabody for cancerbehandling
NO991161D0 (no) TNF-<beta>-lignende protein for behandling av prostatakreft, og beslektede nukleinsyremolekyler, farmas°ytiske sammensetninger og metoder
WO2003076610A3 (fr) Variants de kallikrein-2 et kallikrein-3 humaines et leurs utilisations

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application